InsiderClue
Stocks · Health care · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Zimmer Biomet

ZBH Clue Score43
United States Fiscal year ends December CIK 0001136869
$89.14 +0.29% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $89.14 −38.01% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue7.67Operating income0.82Net income0.31EPS, diluted1.51Fiscal year 2017Revenue7.80 +1.8%Operating income0.80Net income1.81 +492.9%EPS, diluted8.90 +489.4%Fiscal year 2018Revenue7.93 +1.7%Operating income0.03Net income−0.38 −120.9%EPS, diluted−1.86 −120.9%Fiscal year 2019Revenue7.98 +0.6%Operating income1.14Net income1.13EPS, diluted5.47Fiscal year 2020Revenue6.13 −23.2%Operating income0.08Net income−0.14 −112.3%EPS, diluted−0.67 −112.2%Fiscal year 2021Revenue6.83 +11.4%Operating income0.86Net income0.40EPS, diluted1.91Fiscal year 2022Revenue6.94 +1.6%Operating income0.70Net income0.23 −42.4%EPS, diluted1.10 −42.4%Fiscal year 2023Revenue7.39 +6.5%Operating income1.28Net income1.02 +342.5%EPS, diluted4.88 +343.6%Fiscal year 2024Revenue7.68 +3.8%Operating income1.29Net income0.90 −11.7%EPS, diluted4.43 −9.2%Fiscal year 2025Revenue8.23 +7.2%Operating income1.10Net income0.71 −22.0%EPS, diluted3.55 −19.9%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 7.67 7.80 7.93 7.98 6.13 6.83 6.94 7.39 7.68 8.23
Growth +1.8% +1.7% +0.6% −23.2% +11.4% +1.6% +6.5% +3.8% +7.2%
Operating income 0.82 0.80 0.03 1.14 0.08 0.86 0.70 1.28 1.29 1.10
Net income 0.31 1.81 −0.38 1.13 −0.14 0.40 0.23 1.02 0.90 0.71
Growth +492.9% −120.9% −112.3% −42.4% +342.5% −11.7% −22.0%
EPS, diluted 1.51 8.90 −1.86 5.47 −0.67 1.91 1.10 4.88 4.43 3.55
Growth +489.4% −120.9% −112.2% −42.4% +343.6% −9.2% −19.9%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin10.7%Net margin4.0%Free cash flow margin18.9%Fiscal year 2017Operating margin10.2%Net margin23.2%Free cash flow margin18.3%Fiscal year 2018Operating margin0.4%Net margin−4.8%Free cash flow margin20.0%Fiscal year 2019Operating margin14.3%Net margin14.2%Free cash flow margin17.3%Fiscal year 2020Operating margin1.4%Net margin−2.3%Free cash flow margin17.8%Fiscal year 2021Operating margin12.6%Net margin5.9%Free cash flow margin19.9%Fiscal year 2022Operating margin10.0%Net margin3.3%Free cash flow margin16.8%Fiscal year 2023Operating margin17.3%Net margin13.8%Free cash flow margin17.5%Fiscal year 2024Operating margin16.7%Net margin11.8%Free cash flow margin16.9%Fiscal year 2025Operating margin13.3%Net margin8.6%Free cash flow margin17.9%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin 10.7% 10.2% 0.4% 14.3% 1.4% 12.6% 10.0% 17.3% 16.7% 13.3%
Net margin 4.0% 23.2% −4.8% 14.2% −2.3% 5.9% 3.3% 13.8% 11.8% 8.6%
Free cash flow margin 18.9% 18.3% 20.0% 17.3% 17.8% 19.9% 16.8% 17.5% 16.9% 17.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow1.63Capital expenditure−0.18Free cash flow1.45Buybacks−0.42Dividends paid−0.19Fiscal year 2017Operating cash flow1.58Capital expenditure−0.16Free cash flow1.43 −1.5%Dividends paid−0.19Fiscal year 2018Operating cash flow1.75Capital expenditure−0.16Free cash flow1.58 +11.1%Dividends paid−0.20Fiscal year 2019Operating cash flow1.59Capital expenditure−0.21Free cash flow1.38 −13.0%Dividends paid−0.20Fiscal year 2020Operating cash flow1.20Capital expenditure−0.11Free cash flow1.09 −20.8%Dividends paid−0.20Fiscal year 2021Operating cash flow1.50Capital expenditure−0.14Free cash flow1.36 +24.1%Dividends paid−0.20Fiscal year 2022Operating cash flow1.36Capital expenditure−0.19Free cash flow1.17 −13.8%Buybacks−0.13Dividends paid−0.20Fiscal year 2023Operating cash flow1.58Capital expenditure−0.29Free cash flow1.29 +10.5%Buybacks−0.69Dividends paid−0.20Fiscal year 2024Operating cash flow1.50Capital expenditure−0.20Free cash flow1.30 +0.4%Buybacks−0.87Dividends paid−0.20Fiscal year 2025Operating cash flow1.70Capital expenditure−0.22Free cash flow1.47 +13.7%Buybacks−0.49Dividends paid−0.19
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 1.63 1.58 1.75 1.59 1.20 1.50 1.36 1.58 1.50 1.70
Capital expenditure −0.18 −0.16 −0.16 −0.21 −0.11 −0.14 −0.19 −0.29 −0.20 −0.22
Free cash flow 1.45 1.43 1.58 1.38 1.09 1.36 1.17 1.29 1.30 1.47
Growth −1.5% +11.1% −13.0% −20.8% +24.1% −13.8% +10.5% +0.4% +13.7%
Buybacks −0.42 n/a n/a n/a n/a n/a −0.13 −0.69 −0.87 −0.49
Dividends paid −0.19 −0.19 −0.20 −0.20 −0.20 −0.20 −0.20 −0.20 −0.20 −0.19

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash0.63Total debt11.24Net cash (debt)−10.61Shareholders’ equity9.67Debt to equity1.16Fiscal year 2017Cash0.52Total debt10.14Net cash (debt)−9.62Shareholders’ equity11.74Debt to equity0.86Fiscal year 2018Cash0.54Total debt8.94Net cash (debt)−8.40Shareholders’ equity11.27Debt to equity0.79Fiscal year 2019Cash0.62Total debt8.22Net cash (debt)−7.60Shareholders’ equity12.39Debt to equity0.66Fiscal year 2020Cash0.80Total debt8.13Net cash (debt)−7.32Shareholders’ equity12.19Debt to equity0.67Fiscal year 2021Cash0.38Total debt7.07Net cash (debt)−6.69Shareholders’ equity12.66Debt to equity0.56Fiscal year 2022Cash0.38Total debt5.70Net cash (debt)−5.32Shareholders’ equity12.02Debt to equity0.47Fiscal year 2023Cash0.42Total debt5.77Net cash (debt)−5.35Shareholders’ equity12.48Debt to equity0.46Fiscal year 2024Cash0.53Total debt6.20Net cash (debt)−5.68Shareholders’ equity12.47Debt to equity0.50Fiscal year 2025Cash0.59Total debt7.52Net cash (debt)−6.93Shareholders’ equity12.70Debt to equity0.59
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.63 0.52 0.54 0.62 0.80 0.38 0.38 0.42 0.53 0.59
Total debt 11.24 10.14 8.94 8.22 8.13 7.07 5.70 5.77 6.20 7.52
Net cash (debt) −10.61 −9.62 −8.40 −7.60 −7.32 −6.69 −5.32 −5.35 −5.68 −6.93
Shareholders’ equity 9.67 11.74 11.27 12.39 12.19 12.66 12.02 12.48 12.47 12.70
Debt to equity 1.16 0.86 0.79 0.66 0.67 0.56 0.47 0.46 0.50 0.59

In billions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In billions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
7.67 7.80 7.93 7.98 6.13 6.83 6.94 7.39 7.68 8.23
Growth +1.8% +1.7% +0.6% −23.2% +11.4% +1.6% +6.5% +3.8% +7.2%
2.38 2.13 2.27 2.25 1.82 1.96 2.02 2.08 2.19 2.49
2.94 3.10 3.38 3.34 2.71 2.84 2.76 2.84 2.93 3.26
0.82 0.80 0.03 1.14 0.08 0.86 0.70 1.28 1.29 1.10
Growth −2.7% −95.8% +3,265.4% −92.7% +935.3% −19.1% +83.5% +0.6% −14.6%
0.40 0.46 −0.27 0.91 −0.11 0.50 0.40 1.07 1.04 0.83
0.10 −1.35 0.11 −0.23 −0.10 0.05 0.11 0.04 0.13 0.13
0.31 1.81 −0.38 1.13 −0.14 0.40 0.23 1.02 0.90 0.71
Growth +492.9% −120.9% −112.3% −42.4% +342.5% −11.7% −22.0%
Per share
1.53 8.98 −1.86 5.52 −0.67 1.93 1.10 4.91 4.45 3.56
1.51 8.90 −1.86 5.47 −0.67 1.91 1.10 4.88 4.43 3.55
Growth +489.4% −120.9% −112.2% −42.4% +343.6% −9.2% −19.9%
200.0 201.9 203.5 205.1 207.0 208.6 209.6 208.7 203.1 198.0
202.4 203.7 203.5 206.7 207.0 210.4 210.3 209.7 203.9 198.7
Growth +0.6% −0.1% +1.6% +0.1% +1.6% −0.0% −0.3% −2.8% −2.6%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 6.1% a year over five years.
  • The diluted share count fell 4.0% in five years, so buybacks did some of the work per share.
  • Operating margin is up 12.0 points on five years ago, at 13.3%.
  • A net loss in 2 of 10 years on file.